TopAbstracts in Pain 08/28/2008 TopAbstracts in Pain are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide newsletter or visited a website Powered by Doctor's Guide in the past 7 days.Over 2000 peer-reviewed journals...
Subdissociative-dose Ketamine versus Fentanyl for Analgesia during Propofol Procedural Sedation: A Randomized Objectives: The authors sought to compare the safety and efficacy of subdissociative-dose ketamine versus fentanyl as adjunct analgesics for emergency department (ED) procedural sedation and analgesia (PSA) with propofol.Methods: This...
Morphine With Adjuvant Ketamine Vs. Higher Doses Of Morphine Alone For Immediate Post-thoracotomy Analgesia 1Department of Cardiothoracic Surgery, email: nachumnesher@yahoo.com 2Department of Anesthesia and Intensive Care Medicine, email: margaret.ekstein@med.nyu.edu 3Department of Cardiothoracic Surgery, email: ypaz@tasmc.health.gov.il 4Acute...
Ketamine use in prehospital critical care Search the BMJ Emergency Medicine Journal 2008;25:618-619 2008 BMJ Publishing Group Ltd, and British Association for Accident and Emergency Medicine This Article Google Scholar A Steel, R Wharton, A Bates, J French, S Lewis, R Mackenzie...
Javelin Presents PMI-150 (Intranasal Ketamine) Data at Premier Department of Defense Scientific Meeting - Javelin Pharmaceuticals, Inc.(AMEX:JAV), a leading developer of novel products for pain management, is presenting data today on its PMI-150 drug candidate (intranasal ketamine for acute pain) at the Department of Defense's (DoD) 2008...
Javelin Presents PMI-150 (Intranasal Ketamine) Data at Premier Department of Defense Scientific Meeting - Javelin Pharmaceuticals, Inc.(AMEX:JAV), a leading developer of novel products for pain management, is presenting data today on its PMI-150 drug candidate (intranasal ketamine for acute pain) at the Department of Defense's (DoD) 2008...
Javelin Presents PMI-150 (Intranasal Ketamine) Data at Premier Department of Defense Scientific Meeting , 8:30 AM EST News source: Business Wire Javelin Pharmaceuticals, Inc.(AMEX:JAV), a leading developer of novel products for pain management, is presenting data today on its PMI-150 drug candidate (intranasal ketamine for acute pain) at...
Javelin Presents PMI-150 (Intranasal Ketamine) Data at Premier Department of Defense Scientific Meeting - Javelin Pharmaceuticals, Inc.(AMEX:JAV), a leading developer of novel products for pain management, is presenting data today on its PMI-150 drug candidate (intranasal ketamine for acute pain) at the Department of Defense's (DoD) 2008...
Javelin Pharmaceuticals Enrolls First Patient in Pivotal Trial for PMI-150 - Javelin Pharmaceuticals, Inc.(AMEX: JAV) announced dosing of the first patient in its pivotal Phase 3 clinical study of PMI-150 (intranasal ketamine) for acute pain.
The trial is expected to enroll approximately 200 patients and is...
